Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (151-160 of 497) with videos related to

Pageof 50
Sort By:
Cancer Medicine|March 20, 2023
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinomaMarco Silvestri, Trung Nghia Vu, Federico Nichetti, et al.
The Annals of Thoracic Surgery|December 23, 2006
Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan eraTommaso M De Pas, Filippo de Braud, Gianpiero Catalano, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2006
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patientsTommaso De Pas, Carlo Putzu, Giuseppe Curigliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Tumori|July 30, 2016
Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experienceStefano Cavalieri, Lorenza Di Guardo, Carolina Cimminiello, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
International Journal of Molecular Sciences|November 17, 2019
The Landscape of Actionable Gene Fusions in Colorectal CancerFilippo Pagani, Giovanni Randon, Vincenzo Guarini, et al.
Oncotarget|December 19, 2015
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockadeIlaria Penna, Alessandra Molla, Giulia Grazia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.
Critical Reviews in Oncology/Hematology|December 9, 2008
Rectal cancerMaria Giulia Zampino, Roberto Labianca, Giordano D Beretta, et al.
Pageof 50

Showing results (151-160 of 497) with videos related to

Sort By:
Pageof 50
Cancer Medicine|March 20, 2023
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinomaMarco Silvestri, Trung Nghia Vu, Federico Nichetti, et al.
The Annals of Thoracic Surgery|December 23, 2006
Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan eraTommaso M De Pas, Filippo de Braud, Gianpiero Catalano, et al.
Lung Cancer (Amsterdam, Netherlands)|October 10, 2006
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patientsTommaso De Pas, Carlo Putzu, Giuseppe Curigliano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III TrialHans-Joachim Schmoll, Josep Tabernero, Jean Maroun, et al.
Tumori|July 30, 2016
Combined therapy with dabrafenib and trametinib in BRAF-mutated metastatic melanoma in a real-life setting: the INT Milan experienceStefano Cavalieri, Lorenza Di Guardo, Carolina Cimminiello, et al.
Oncotarget|March 18, 2015
Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cellsMaria Lucibello, Sara Adanti, Ester Antelmi, et al.
International Journal of Molecular Sciences|November 17, 2019
The Landscape of Actionable Gene Fusions in Colorectal CancerFilippo Pagani, Giovanni Randon, Vincenzo Guarini, et al.
Oncotarget|December 19, 2015
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockadeIlaria Penna, Alessandra Molla, Giulia Grazia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerDaniel G Haller, Josep Tabernero, Jean Maroun, et al.
Critical Reviews in Oncology/Hematology|December 9, 2008
Rectal cancerMaria Giulia Zampino, Roberto Labianca, Giordano D Beretta, et al.
Pageof 50